1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Cancer Drug News 12 JANUARY 2015

Cancer Drug News 12 JANUARY 2015

  • January 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Incentives Will Continue To Generate Interest In Orphan Diseases
Industry Trend Analysis - SABCS Highlights Focus On HER2- And PD-1-Targeting Drugs For BC
Industry Brief - KHK/Syndax Sign Deal To Develop Entinostat In Japan/Korea
Industry Brief - Pfizer Updates On Ibrance's Progress
Industry Brief - Kite's KTE-CI9 Gains EU Orphan Medicinal Product Designation For DLBCL
Industry Brief - Soligenix' SGX301 Gains FDA Fast Track Designation For First-Line CTCL
Industry Brief - Imbruvica Shows Efficacy In High-Risk CLL Patients
Industry Brief - Gamida's NiCord Gains ODD In US/Europe
Industry Brief - Chipscreen Receives Chinese Approval For Epidaza In PTCL
Industry Brief - Selinexor Granted ODD For Multiple Myeloma
Industry Brief - Seattle Genetics/BMS Enter Clinical Trial Collaboration For Adcetris/Opdivo
Industry Brief - QIAGEN's Liquid Biopsy For Iressa Secures CE Marking
Industry Brief - MedImmune/Omnis Sign Licensing Deal For Oncolytic Viruses In Immuno-Oncology
Industry Brief - Lion Submits IND For LN-144 Phase II MM Trial
Industry Brief - Nivolumab Receives PMI Status For Advanced Melanoma
Industry Brief - Sobi/Exelixis Extend Cometriq Distribution Agreement
Industry Brief - Amgen/Kite Collaborate To Develop CAR T-Cell Immunotherapies
Industry Brief - Otsuka Reports Termination Of Contracts With OTS/Fuso Pharmaceutical Industries
Industry Brief - Mersana/Takeda Expand Fleximer-ADC Collaboration
Industry Trend Analysis - Incyte/Agenus Collaboration Raises Profile In Immuno-Oncology Market
Industry Brief - First Of Three Sativex Phase III Cancer Pain Trials Misses Primary Endpoint
Industry Brief - Helsinn Reaches Palonosetron Settlement With Sandoz
Industry Trend Analysis - US Approval Of Sandoz' Filgrastim Advances With Small Steps, Not Giant Leaps
Industry Brief - Cardio3 Enters Immuno-Oncology Space With OnCyte Acquisition
Industry Brief - Cipher Snaps Up Melanovus Oncology's Assets

Table Of Contents

Cancer Drug News 12 JANUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Versatile Innovation in Immunology - Large Therapy Area Pipeline with a High Degree of Repositioning Potential

Frontier Pharma: Versatile Innovation in Immunology - Large Therapy Area Pipeline with a High Degree of Repositioning Potential

  • $ 6995
  • Industry report
  • January 2017
  • by GBI Research

Frontier Pharma: Versatile Innovation in Immunology - Large Therapy Area Pipeline with a High Degree of Repositioning Potential Summary Immunology is a large therapy area characterized by disorders of ...

EU5 Ophthalmic Lasers Market Outlook to 2022

EU5 Ophthalmic Lasers Market Outlook to 2022

  • $ 5995
  • Industry report
  • December 2016
  • by Global Data

EU5 Ophthalmic Lasers Market Outlook to 2022 Summary GlobalData’s new report, "EU5 Ophthalmic Lasers Market Outlook to 2022", provides key market data on the EU5 Ophthalmic Lasers market. The report ...

Asia-Pacific Ophthalmic Lasers Market Outlook to 2022

Asia-Pacific Ophthalmic Lasers Market Outlook to 2022

  • $ 5995
  • Industry report
  • December 2016
  • by Global Data

Asia-Pacific Ophthalmic Lasers Market Outlook to 2022 Summary GlobalData’s new report, "Asia-Pacific Ophthalmic Lasers Market Outlook to 2022", provides key market data on the Asia-Pacific Ophthalmic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.